Cardiac MRI—Update 2020

Busse, Anke; Rajagopal, Rengarajan; Yücel, Seyrani; Beller, Ebba; Streckenbach, Felix; Cantré, Daniel; İnce, Hüseyin; Weber, Marc André; Meinel, Felix G.

doi:10.1007/s00117-020-00687-1

Cited by 25 publications

(23 citation statements)

References 42 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The studies had a range of utilized methods, with most using CMR, echocardiography, ECG and biomarkers’ measurement. However, most positive findings came from CMR, which has higher sensitivity for detecting myocardial damage ( 53 ) and in line with studies using these methods concomitantly to detect cardiac pathology ( 20 , 29 , 34 ).…”

Section: Discussionsupporting

confidence: 66%

Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review

Ramadan

Bertolino

Zampino

et al. 2021

Clinical Microbiology and Infection

View full text Add to dashboard Cite

Background Coronavirus disease 2019 (COVID-19) has been implicated in a wide spectrum of cardiac manifestations following the acute phase of the disease. Objectives To assess the range of cardiac sequelae after COVID-19 recovery. Data sources PubMed, Embase, Scopus (inception through 17 February 2021), and Google scholar (2019 through 17 February 2021). Study eligibility criteria Prospective and retrospective studies, case reports and case series. Participants Adult patients assessed for cardiac manifestations after COVID-19 recovery. Exposure Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection diagnosed by polymerase chain reaction (PCR). Methods Systematic review. Results Thirty-five studies (fifteen prospective cohort, seven case reports, five cross-sectional, four case series, three retrospective cohort and one ambidirectional cohort) evaluating cardiac sequelae in 52609 patients were included. Twenty-nine studies utilized objective cardiac assessments, mostly cardiac magnetic resonance imaging (CMR) in sixteen studies, echocardiography in fifteen, electrocardiography (ECG) in sixteen and cardiac biomarkers in eighteen. Most studies had a fair risk of bias. The median time from diagnosis/recovery to cardiac assessment was 48 days (1-180). Common short-term cardiac abnormalities (<3 months) included increased T1 (proportion: 30%), T2 (16%), pericardial effusion (15%) and late gadolinium enhancement (LGE, 11%) on CMR, with symptoms such as chest pain (25%) and dyspnea (36%). In the medium term (3-6 months), common changes included reduced left ventricular global longitudinal strain (30%) and LGE (10%) on CMR, diastolic dysfunction (40%) on echocardiography and elevated NT-proBNP (18%). In addition, COVID-19 survivors had higher risk (RR = 3; 95% CI: 2.7-3.2) of developing heart failure, arrythmias and myocardial infarction. Conclusions COVID-19 appears to be associated with persistent/de novo cardiac injury after recovery, particularly subclinical myocardial injury in the earlier phase and diastolic dysfunction later. Larger well-designed and controlled studies with baseline assessments are needed to better measure the extent of cardiac injury and its clinical impact.

show abstract

Section: Discussionsupporting

confidence: 66%

Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review

Ramadan

Bertolino

Zampino

et al. 2021

Clinical Microbiology and Infection

View full text Add to dashboard Cite

show abstract

“…CMRI represents the gold standard for the noninvasive cardiac tissue characterization, detection of acute and chronic myocardial changes, and myocardial viability [9][10][11][12].…”

Section: Cmri and Cardiac Tissue Characterizationmentioning

confidence: 99%

“…LGE imaging represents a cornerstone of CMRI as it is used to define chronic myocardial fibrosis and necrosis caused by ischemia as well as myocardial fibrosis frequently present in non-ischemic dilated cardiomyopathy. Damaged cardiac tissue has a slower gadolinium washout time than healthy tissue, which allows for not only identification of myocardial scarring, but also its quantification [11,12,18]. LGE images of COVID-19 patients suspected of myocardial involvement revealed enhancement at the left ventricular base, suggestive of myocarditis (Figure 1).…”

Section: Late Gadolinium Enhancementmentioning

confidence: 99%

Role of cardiac magnetic resonance imaging in the diagnosis and management of COVID-19 related myocarditis: Clinical and imaging considerations

Atri

Morgan

Harrell

et al. 2021

WJR

View full text Add to dashboard Cite

show abstract

“…Aktuelle Entwicklungen in der kardialen Magnetresonanztomographie (CMR) haben zuletzt einige Limitationen konventioneller, etablierter CMR-Sequenzen überwunden. Beschleunigte Bildakquisitionstechniken wie "compressed sensing", die Möglichkeit der absoluten Quantifizierbarkeit auch diffuser myokardialer Veränderungen mittels myokardialem Mapping oder neue Postprocessing-Anwendungen wie "strain imaging" erweitern die Effizienz und den klinischen Nutzen der CMR in einer Vielzahl von Herzerkrankungen [1]. Mittlerweile finden sich in 54 % aller Leitlinien der europäischen kardiologischen Gesellschaft (ESC Guidelines) Empfehlungen zur Anwendung der CMR [2].…”

Section: Trends Und Entwicklungenunclassified

Kardiale Magnetresonanztomographie

2020

View full text Add to dashboard Cite

Zusammenfassung Hintergrund Durch die Entwicklung robuster Techniken und deren umfassender Validierung hat sich die kardiale Magnetresonanztomographie (CMR) in ihrem knapp 25-jährigen klinischen Einsatz ein breites Indikationsspektrum erarbeitet. Die Erfassung kardialer Volumina und systolischer Ventrikelfunktion sowie die Charakterisierung fokaler Myokardnarben sind heute Teil der CMR-Standard-Bildgebung. Zuletzt haben die Einführung beschleunigter Bildakquisitionstechnologien, die neuen Bildgebungsmethoden des myokardialen T1- und T2-Mappings und der 4‑D-Flussmessungen sowie die neue Postprocessing-Technik des myokardialen Feature-Trackings an Relevanz gewonnen. Methode Diese Überblicksarbeit basiert auf einer umfassenden Literaturrecherche in der PubMed-Datenbank zu neuen CMR-Techniken und ihrer klinischen Anwendung. Ergebnisse und Schlussfolgerung Dieser Artikel zeigt eine Übersicht über die neuesten technischen Entwicklungen im Bereich der CMR sowie deren Anwendungsmöglichkeiten anhand der wichtigsten klinischen Fragestellungen.

show abstract

Cardiac MRI—Update 2020

Cited by 25 publications

References 42 publications

Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review

Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review

Role of cardiac magnetic resonance imaging in the diagnosis and management of COVID-19 related myocarditis: Clinical and imaging considerations

Kardiale Magnetresonanztomographie

Contact Info

Product

Resources

About